查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594054

更年期市场：按治疗方法、产品类型、适应症、分销问题划分 - 2025-2030 年全球预测

Menopause Market by Treatment (Dietary Supplements, OTC Pharma Products), Product Type (Gel, Injection, Oral Dosage), Indication, Distribution Challenge - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年更年期市值为177.9亿美元，预计到2024年将达到189.9亿美元，复合年增长率为6.85%，到2030年将达到282.9亿美元。

更年期是一种自然的生物转变，标誌着女性生殖期的结束，涉及重大的生理变化，因此需要了解其对从药物到生活方式和健康产品等各个领域的影响。更年期相关产品的需求源于全球越来越多的老年女性出现潮热、情绪变化和骨质疏鬆症等症状，从而推动了医疗、个人护理和营养领域的需求。主要应用包括荷尔蒙补充疗法(HRT)、非荷尔蒙治疗、补充品和旨在缓解症状的生活方式产品。最终用户范围从医疗提供者到购买商业产品的消费者。市场成长受到意识提高、医疗保健支出增加以及技术和产品配方进步等因素的影响。社会向个人化健康和综合医学的转变为数位健康平台提供了新的机会，特别是那些提供客製化解决方案和远端咨询的平台。天然和有机产品的开发机会也在扩大，反映了洁净标示和永续产品的趋势。与科技公司建立策略合作伙伴关係来开髮用于症状追踪和管理的应用程式也可能是有益的。然而，挑战依然存在，包括监管障碍、与更年期相关的耻辱，以及传统治疗方法的潜在副作用，这些可能会让一些消费者望而却步。不同国家的监管复杂性也可能阻碍市场成长。创新应着重于开发经临床检验的非侵入性解决方案，以解决症状且无副作用，例如植物疗法和人工智慧驱动的健康管理工具。减轻更年期对心理健康影响的研究以及利用生物技术进行更有效的治疗可能会带来显着的好处。总体而言，更年期市场正在不断发展，并且透过技术进步和消费者教育具有巨大的成长空间，但必须利用监管环境和文化意识来最大限度地发挥潜力。

主要市场统计
基准年[2023] 177.9亿美元
预测年份 [2024] 189.9亿美元
预测年份 [2030] 282.9亿美元
复合年增长率（%） 6.85%

市场动态：揭示快速发展的更年期市场的关键市场洞察

供需的动态交互作用正在改变更年期市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 血管舒缩症状和其他更年期症状的发生率很高
    • 健康意识不断增强
    • 新药认证数量增加
  • 市场限制因素
    • 与荷尔蒙药物相关的副作用和学名药的可用性
  • 市场机会
    • 更年期疾病草药疗法的普及
    • 越来越多的研究支持食品补充剂的益处
  • 市场问题
    • 开发中国家缺乏先进的医疗基础设施

波特的五力：驾驭更年期市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解外部对更年期市场的影响

外部宏观环境因素在塑造更年期市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解更年期市场的竞争格局

对更年期市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：更年期市场供应商绩效评估

FPNV定位矩阵是评估更年期市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製更年期市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，更年期市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 血管舒缩症状和其他更年期症状的发生率很高
      • 提高更年期健康意识
      • 新药认证数量增加
    • 抑制因素
      • 与荷尔蒙药物相关的副作用和学名药的可用性
    • 机会
      • 草药治疗更年期疾病的流行
      • 越来越多的研究支持食品补充剂的益处
    • 任务
      • 开发中国家缺乏先进的医疗基础设施
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章更年期市场：依治疗分类

  • 介绍
  • 食品补充品
  • 非处方药
    • 荷尔蒙产品
      • 雌激素与其他药物合併使用
      • 雌激素和黄体素的复方药物
      • 仅雌激素药物
      • 仅含黄体素的药物
    • 非荷尔蒙产品

第七章更年期市场：依产品类型

  • 介绍
  • 凝胶
  • 注射
  • 口服剂量
  • 修补
  • 丸
  • 粉末
  • 保养霜
  • 皮肤喷雾（经皮）
  • 阴道软膏
  • 避孕环

第八章更年期市场：依适应症分类

  • 介绍
  • 干眼症
  • 干性皮肤
  • 潮热
  • 情绪波动、轻度忧郁症、烦躁
  • 盗汗和发冷
  • 骨质疏鬆症
  • 睡眠障碍
  • 尿急
  • 阴道干燥

第九章更年期疾病市场：依分布问题

  • 介绍
  • 医院药房
  • 网路商店
  • 零售药房

第十章 北美和南美更年期市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太更年期市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的更年期市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbvie Inc.
  • Apotex Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Cipla Inc.
  • Eli Lilly and Company
  • Fervent Pharmaceuticals, LLC
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Ltd.
  • Merck & Co.Inc.
  • Mithra Pharmaceuticals
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD Inc.
Product Code: MRR-B973EDD5E621

The Menopause Market was valued at USD 17.79 billion in 2023, expected to reach USD 18.99 billion in 2024, and is projected to grow at a CAGR of 6.85%, to USD 28.29 billion by 2030.

Menopause, a natural biological transition marking the end of a woman's reproductive years, involves significant physiological changes, necessitating comprehensive market research to understand its implications across various sectors, from pharmaceuticals to lifestyle and wellness products. The necessity for menopause-related products arises from the increasing global population of aging women experiencing symptoms such as hot flashes, mood changes, and osteoporosis, thereby driving demand in healthcare, personal care, and nutritional sectors. The primary applications encompass hormone replacement therapies (HRT), non-hormonal treatments, supplements, and lifestyle products aimed at alleviating symptoms. End-users range from healthcare providers to consumers purchasing over-the-counter products. Market growth is influenced by factors such as growing awareness, increased healthcare spending, and advancements in technology and product formulations. Societal shifts toward personalized health and integrative medicine provide new opportunities, especially in digital health platforms that offer tailored solutions and remote consultations. Opportunities extend to the development of natural and organic offerings, reflecting trends toward clean label and sustainable products. Strategic partnerships with tech firms to develop apps for symptom tracking and management can also be beneficial. However, challenges persist, including regulatory hurdles, the stigma associated with menopause, and potential side effects of conventional therapies, which may deter some consumers. The complexity of differing national regulations can also impede market growth. Innovation should focus on the development of clinically validated, non-invasive solutions that address symptoms without adverse effects, such as plant-based therapies and AI-powered health management tools. Research into mitigating menopause's impact on mental health and the use of biotech for more effective treatments could offer substantial gains. Overall, the menopause market is evolving, with significant scope for growth through technological advancement and consumer education, yet requires navigation of regulatory landscapes and cultural perceptions to maximize potential.

KEY MARKET STATISTICS
Base Year [2023] USD 17.79 billion
Estimated Year [2024] USD 18.99 billion
Forecast Year [2030] USD 28.29 billion
CAGR (%) 6.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Menopause Market

The Menopause Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of vasomotor and other menopausal symptoms
    • Rising awareness regarding menopause health
    • Increasing number of new drug approvals for the treatment
  • Market Restraints
    • Side effects associated with hormonal products and the availability of generic medicines
  • Market Opportunities
    • Prevalence of herbal treatment for menopause
    • Increasing research supporting the advantages of dietary supplements
  • Market Challenges
    • Lack of advanced healthcare infrastructure in developing nations

Porter's Five Forces: A Strategic Tool for Navigating the Menopause Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Menopause Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Menopause Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Menopause Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Menopause Market

A detailed market share analysis in the Menopause Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Menopause Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Menopause Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Menopause Market

A strategic analysis of the Menopause Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Menopause Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Apotex Inc., Astellas Pharma Inc., Bayer AG, Cipla Inc., Eli Lilly and Company, Fervent Pharmaceuticals, LLC, GlaxoSmithKline plc, Glenmark Pharmaceuticals Ltd., Merck & Co.Inc., Mithra Pharmaceuticals, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and TherapeuticsMD Inc..

Market Segmentation & Coverage

This research report categorizes the Menopause Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment, market is studied across Dietary Supplements and OTC Pharma Products. The OTC Pharma Products is further studied across Hormonal products and Non-hormonal products. The Hormonal products is further studied across Combination Estrogen and Other Medicines, Combination Estrogen and Progestin Medicines, Estrogen-Only Medicines, and Progestin-Only Medicines.
  • Based on Product Type, market is studied across Gel, Injection, Oral Dosage, Patch, Pill, Powder, Skin Cream, Skin Spray (Transdermal), Vaginal Cream, and Vaginal Ring.
  • Based on Indication, market is studied across Dry Eyes, Dry Skin, Hot Flashes, Mood Swings, Mild depression & Irritability, Night Sweats and Cold Flashes., Osteoporosis, Trouble Sleeping, Urinary Urgency, and Vaginal Dryness.
  • Based on Distribution Challenge, market is studied across Hospital Pharmacies, Online Stores, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of vasomotor and other menopausal symptoms
      • 5.1.1.2. Rising awareness regarding menopause health
      • 5.1.1.3. Increasing number of new drug approvals for the treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with hormonal products and the availability of generic medicines
    • 5.1.3. Opportunities
      • 5.1.3.1. Prevalence of herbal treatment for menopause
      • 5.1.3.2. Increasing research supporting the advantages of dietary supplements
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of advanced healthcare infrastructure in developing nations
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Menopause Market, by Treatment

  • 6.1. Introduction
  • 6.2. Dietary Supplements
  • 6.3. OTC Pharma Products
    • 6.3.1. Hormonal products
      • 6.3.1.1. Combination Estrogen and Other Medicines
      • 6.3.1.2. Combination Estrogen and Progestin Medicines
      • 6.3.1.3. Estrogen-Only Medicines
      • 6.3.1.4. Progestin-Only Medicines
    • 6.3.2. Non-hormonal products

7. Menopause Market, by Product Type

  • 7.1. Introduction
  • 7.2. Gel
  • 7.3. Injection
  • 7.4. Oral Dosage
  • 7.5. Patch
  • 7.6. Pill
  • 7.7. Powder
  • 7.8. Skin Cream
  • 7.9. Skin Spray (Transdermal)
  • 7.10. Vaginal Cream
  • 7.11. Vaginal Ring

8. Menopause Market, by Indication

  • 8.1. Introduction
  • 8.2. Dry Eyes
  • 8.3. Dry Skin
  • 8.4. Hot Flashes
  • 8.5. Mood Swings, Mild depression & Irritability
  • 8.6. Night Sweats and Cold Flashes.
  • 8.7. Osteoporosis
  • 8.8. Trouble Sleeping
  • 8.9. Urinary Urgency
  • 8.10. Vaginal Dryness

9. Menopause Market, by Distribution Challenge

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Stores
  • 9.4. Retail Pharmacies

10. Americas Menopause Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Menopause Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Menopause Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbvie Inc.
  • 2. Apotex Inc.
  • 3. Astellas Pharma Inc.
  • 4. Bayer AG
  • 5. Cipla Inc.
  • 6. Eli Lilly and Company
  • 7. Fervent Pharmaceuticals, LLC
  • 8. GlaxoSmithKline plc
  • 9. Glenmark Pharmaceuticals Ltd.
  • 10. Merck & Co.Inc.
  • 11. Mithra Pharmaceuticals
  • 12. Novartis AG
  • 13. Pfizer Inc.
  • 14. Teva Pharmaceutical Industries Ltd.
  • 15. TherapeuticsMD Inc.

LIST OF FIGURES

  • FIGURE 1. MENOPAUSE MARKET RESEARCH PROCESS
  • FIGURE 2. MENOPAUSE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MENOPAUSE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MENOPAUSE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MENOPAUSE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MENOPAUSE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MENOPAUSE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MENOPAUSE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MENOPAUSE MARKET DYNAMICS
  • TABLE 7. GLOBAL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MENOPAUSE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MENOPAUSE MARKET SIZE, BY COMBINATION ESTROGEN AND OTHER MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MENOPAUSE MARKET SIZE, BY COMBINATION ESTROGEN AND PROGESTIN MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MENOPAUSE MARKET SIZE, BY ESTROGEN-ONLY MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MENOPAUSE MARKET SIZE, BY PROGESTIN-ONLY MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MENOPAUSE MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MENOPAUSE MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MENOPAUSE MARKET SIZE, BY ORAL DOSAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MENOPAUSE MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MENOPAUSE MARKET SIZE, BY PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MENOPAUSE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MENOPAUSE MARKET SIZE, BY SKIN CREAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MENOPAUSE MARKET SIZE, BY SKIN SPRAY (TRANSDERMAL), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MENOPAUSE MARKET SIZE, BY VAGINAL CREAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MENOPAUSE MARKET SIZE, BY VAGINAL RING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MENOPAUSE MARKET SIZE, BY DRY EYES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MENOPAUSE MARKET SIZE, BY DRY SKIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MENOPAUSE MARKET SIZE, BY HOT FLASHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL MENOPAUSE MARKET SIZE, BY MOOD SWINGS, MILD DEPRESSION & IRRITABILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL MENOPAUSE MARKET SIZE, BY NIGHT SWEATS AND COLD FLASHES., BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL MENOPAUSE MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL MENOPAUSE MARKET SIZE, BY TROUBLE SLEEPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL MENOPAUSE MARKET SIZE, BY URINARY URGENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL MENOPAUSE MARKET SIZE, BY VAGINAL DRYNESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH KOREA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 143. TAIWAN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 144. TAIWAN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 145. TAIWAN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. TAIWAN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 149. THAILAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 150. THAILAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 151. THAILAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. THAILAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. THAILAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 155. VIETNAM MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 156. VIETNAM MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 157. VIETNAM MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. VIETNAM MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. VIETNAM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 168. DENMARK MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 169. DENMARK MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 170. DENMARK MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. DENMARK MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. DENMARK MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 173. EGYPT MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 174. EGYPT MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 175. EGYPT MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 176. EGYPT MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. EGYPT MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 178. EGYPT MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 179. FINLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 180. FINLAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 181. FINLAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 182. FINLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. FINLAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. FINLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 185. FRANCE MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 186. FRANCE MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 187. FRANCE MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 188. FRANCE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. FRANCE MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. FRANCE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 191. GERMANY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 192. GERMANY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 193. GERMANY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 194. GERMANY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. GERMANY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 196. GERMANY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 197. ISRAEL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 198. ISRAEL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 199. ISRAEL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 200. ISRAEL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. ISRAEL MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. ISRAEL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 203. ITALY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 204. ITALY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 205. ITALY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 206. ITALY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. ITALY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 208. ITALY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 210. NETHERLANDS MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 212. NETHERLANDS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. NETHERLANDS MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. NETHERLANDS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 215. NIGERIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 216. NIGERIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 217. NIGERIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 218. NIGERIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. NIGERIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. NIGERIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 221. NORWAY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 222. NORWAY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 223. NORWAY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 224. NORWAY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. NORWAY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 226. NORWAY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 227. POLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 228. POLAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 229. POLAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 230. POLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. POLAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 232. POLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 233. QATAR MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 234. QATAR MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 235. QATAR MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 236. QATAR MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. QATAR MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 238. QATAR MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 239. RUSSIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 240. RUSSIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 241. RUSSIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 242. RUSSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. RUSSIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 244. RUSSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 246. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 248. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 254. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 257. SPAIN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 258. SPAIN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 259. SPAIN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 260. SPAIN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. SPAIN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 262. SPAIN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 263. SWEDEN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 264. SWEDEN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 265. SWEDEN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 266. SWEDEN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. SWEDEN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 268. SWEDEN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 270. SWITZERLAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 272. SWITZERLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. SWITZERLAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 274. SWITZERLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 275. TURKEY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 276. TURKEY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 277. TURKEY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 278. TURKEY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. TURKEY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 280. TURKEY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 288. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 290. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 292. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 293. MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 294. MENOPAUSE MARKET, FPNV POSITIONING MATRIX, 2023